Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02574390 · ClinicalTrials.gov registry record
Answer ALS: Individualized Initiative for ALS Discovery
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 1,049
- Enrollment target
NCT02574390: Completed study, sponsored by Johns Hopkins University.
NCT02574390 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 1,049 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02574390 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 1,049 participants
- Enrollment target
Study Summary
Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change over time. People with other motor neuron diseases and healthy controls will be included as comparisons
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,049 participants |
| Start Date | 2015-12 |
| Est. Completion | 2020-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02574390
The ClinicalTrials.gov registry entry for NCT02574390 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,049 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02574390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02574390 about?
NCT02574390 is a clinical study titled "Answer ALS: Individualized Initiative for ALS Discovery". Creation of a large repository of induced pluripotent stem cells (iPSC), bio-fluid samples (blood and spinal fluid (optional)), and cell lines for ALS gene identification. This will be combined carefully with collected measures of the pattern of the symptoms people with ALS have and how these change...
What is the current status of trial NCT02574390?
This trial is currently completed. The enrollment target is 1,049 participants. The study started on 2015-12. Estimated completion is 2020-01-01.
Who is sponsoring clinical trial NCT02574390?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.